Regenerative Cell Therapy: CIRM President Mills, Bipartisan Policy Center Kenote

Cell therapies represent one of the most promising areas for the next generation of groundbreaking treatments in the areas of cardiology, neurology, ophthalmology, and orthopedics. New studies for those with Alzheimers’ disease, Parkinson’s disease, heart disease, diabetes, and cancer are encouraging. In this video, CIRM President Randy Mills discusses CIRM's latest efforts to work with the US Food and Drug Administration (FDA) to help accelerate the approval process of stem cell treatments for patients with unmet medical needs. (Video courtesy of the Bipartisan Policy Center).